The effect of loss of excess weight on the metabolic risk factors after bariatric surgery in morbidly and super-obese patients

Obesity Surgery

Volumn 17, Issue 7, 2007, Pages 910-919

  Wolf, Anna Maria ^a   Beisiegel, Ulrike ^b  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Bariatric surgery; Excess weight loss; Metabolic risk factor; Morbid obesity; Super obesity

Indexed keywords

INSULIN; LEPTIN; LIPID; SEX HORMONE; TRIACYLGLYCEROL; URIC ACID;

ADULT; ARTICLE; BARIATRIC SURGERY; BODY MASS; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERINSULINEMIA; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; OBESITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; WEIGHT REDUCTION;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; COHORT STUDIES; FEMALE; GASTROPLASTY; HORMONES; HUMANS; INSULIN; LIPIDS; MALE; MIDDLE AGED; OBESITY, MORBID; RISK FACTORS; SEX FACTORS; TRANSAMINASES; WEIGHT LOSS;

EID: 35748986437     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11695-007-9169-0     Document Type: Article

References (44)

1. Flegal KM. Epidemiologic aspects of overweight and obesity in the United States. Physiol Behav 2005; 86: 599-602.
2. Wilson PW, D'Agostino RB, Sullivan L et al. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 2002; 162: 1867-72.
3. Kim KS, Owen WL, Williams D et al. A comparison between BMI and Conicity index on predicting coronary heart disease: the Framingham Heart Study. Ann Epidemiol 2000;10: 424-31.
4. Mason EE, Tang S, Renquist KE et al. A decade of change in obesity surgery. National Bariatric Surgery Registry (NBSR) Contributors. Obes Surg 1997; 7: 189-97.
5. Busetto L. Visceral obesity and the metabolic syndrome: effects of weight loss. Nutr Metab Cardiovasc Dis 2001; 11: 195-204.
6. Dixon JB, Dixon AF, O'Brien PE. Improvements in insulin sensitivity and beta-cell function (HOMA) with weight loss in the severely obese. Homeostatic model assessment. Diabet Med 2003; 20: 127-34.
7. Hanusch-Enserer U, Cauza E, Spak M et al. Improvement of insulin resistance and early atherosclerosis in patients after gastric banding. Obes Res 2004; 12: 284-291.
8. Nedelnikova K, Svacina S, Haas T et al. Influence of metabolic state and diabetes on the outcome at the end of first year after gastric banding. Obes Surg 2000; 10: 372-5.
9. Ponce J, Haynes B, Paynter S et al. Effect of Lap-Bandinduced weight loss on type 2 diabetes mellitus and hypertension. Obes Surg 2004; 14: 1335-42.
10. Pories WJ. Why Does the gastric bypass control ttype 2 diabetes mellitus? Obes Surg 1992; 2: 303-13.
11. Sjostrom CD, Lissner L, Wedel H et al. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes Res 1999;7:477-484.
12. Sjostrom L, Lindroos AK, Peltonen M et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351: 2683-93.
13. Wolf AM, Beisiegel U, Kortner B et al. Does gastric restriction surgery reduce the risks of metabolic diseases? Obes Surg 1998; 8: 9-13.
14. Wirth A. Reduction of body weight and co-morbidities by orlistat: The XXL - Primary Health Care Trial. Diabetes Obes Metab 2005; 7: 21-7.
15. Goldstein DJ. Beneficial health effects of modest weight loss. Int J Obes 1992; 16: 397-415.
16. Mason EE, Doherty C, Maher JW et al. Super obesity and gastric reduction procedures. Gastroenterol Clin North Am 1987; 16: 495-502.
17. MacLean LD, Rhode BM, Forse RA. Late results of vertical banded gastroplasty for morbid and super obesity. Surgery 1990; 107: 20-7.
18. Wolf AM, Buffington C, Beisiegel U. Comparison of metabolic risk factors between severely and very severely obese patients. Obesity 2006; 14: 2177-83.
19. Melissas J, Christodoulakis M, Schoretsanitis G et al. Obesity-associated disorders before and after weight reduction by vertical banded gastroplasty in morbidly vs super obese individuals. Obes Surg 2001; 11: 475-81.
20. Bloomston M, Zervos EE, Camps MA et al. Outcome following bariatric surgery in super versus morbidly obese patients: does weight matter? Obes Surg 1997; 7: 414-9.
21. Busetto L, Pisent C, Rinaldi D et al. Variation in lipid levels in morbidly obese patients operated with the LAP-BAND adjustable gastric banding system: effects of different levels of weight loss. Obes Surg 2000; 10: 569-77.
22. Gazzaruso C, Giordanetti S, La Manna A et al. Weight loss after Swedish Adjustable Gastric Banding: relationships to insulin resistance and metabolic syndrome. Obes Surg 2002; 12: 841-5.
23. Giusti V, Suter M, Heraief E et al. Effects of laparoscopic gastric banding on body composition, metabolic profile and nutritional status of obese women: 12-months follow-up. Obes Surg 2004; 14: 239-45.
24. Guldstrand M, Ahren B, Adamson U. Improved beta-cell function after standardized weight reduction in severely obese subjects. Am J Physiol Endocrinol Metab 2003; 284: E557-E565.
25. Guidelines for laparoscopic and open surgical treatment of morbid obesity. American Society for Bariatric Surgery. Obes Surg 2000; 10: 378-9.
26. Wenzel H. Definition, Klassifikation und Messung der Adipositas. In: Wechsler JG, ed. Adipositas - Ursachen und Therapie. Berlin Wien: Blackwall Wissenschaftsverlag 1998: 45-61.
27. Considine RV, Sinha MK, Heiman ML et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334: 292-5.
28. Rosenbaum M, Nicolson M, Hirsch J et al. Effects of gender, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab 1996; 81: 3424-7.
29. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
30. De Backer G, Ambrosioni E, Borch-Johnsen K et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts). Atherosclerosis 2004; 173: 381-91.
31. Lean ME, Han TS, Morrison CE. Waist circumference as a measure for indicating need for weight management. BMJ 1995; 311: 158-61.
32. Bjorntorp P. Regional patterns of fat distribution. Ann Intern Med 1985; 103: 994-95.
33. Haciyanli M, Erkan N, Bora S et al. Vertical banded gastroplasty in the Aegean Region of Turkey. Obes Surg 2001; 11: 482-6.
34. Balsiger BM, Poggio JL, Mai J et al. Ten and more years after vertical banded gastroplasty as primary operation for morbid obesity. J Gastrointest Surg 2000; 4: 598-605.
35. Brolin RE. Critical analysis of results: weight loss and quality of data. Am J Clin Nutr 1992; 55: 577S-581S.
36. Isles CG, Paterson JR. Identifying patients at risk for coronary heart disease: implications from trials of lipid-lowering drug therapy. QJM 2000; 93: 567-74.
37. Kannel WB. Lipids, diabetes, and coronary heart disease: insights from the Framingham Study. Am Heart J 1985; 110: 1100-7.
38. Luyckx FH, Scheen AJ, Desaive C et al. Effects of gastroplasty on body weight and related biological abnormalities in morbid obesity. Diabetes Metab 1998; 24: 355-61.
39. Uzun H, Zengin K, Taskin M et al. Changes in leptin, plasminogen activator factor and oxidative stress in morbidly obese patients following open and laparoscopic Swedish adjustable gastric banding. Obes Surg 2004; 14: 659-65.
40. Corradini SG, Eramo A, Lubrano C et al. Comparison of changes in lipid profile after bilio-intestinal bypass and gastric banding in patients with morbid obesity. Obes Surg 2005; 15: 367-77.
41. Dixon JB, O'Brien PE. Lipid profile in the severely obese: changes with weight loss after lap-band surgery. Obes Res 2002; 10: 903-10.
42. Dolan K, Bryant R, Fielding G. Treating diabetes in the morbidly obese by laparoscopic gastric banding. Obes Surg 2003; 13: 439-43.
43. Closset J, Mehdi A, Barea M et al. Results of silastic ring vertical gastroplasty more than 6 years after surgery: analysis of a cohort of 214 patients. Obes Surg 2004; 14: 1233-6.
44. Wolf AM, Busch B, Kuhlmann HW et al. Histological changes in the liver of morbidly obese patients: correlation with metabolic parameters. Obes Surg 2005; 15: 228-37.